These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14686306)

  • 21. HIV drug resistance testing: is the evidence really there?
    Dunn DT; Gibb DM; Babiker AG; Green H; Darbyshire JH; Weller IV
    Antivir Ther; 2004 Oct; 9(5):641-8. PubMed ID: 15535402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
    J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-resistance patterns in women discovered. Resistance testing necessary, expert says.
    AIDS Alert; 2005 Jan; 20(1):7-8. PubMed ID: 15717355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
    Simcock M; Sendi P; Ledergerber B; Keller T; Schüpbach J; Battegay M; Günthard HF;
    Antivir Ther; 2006; 11(3):305-14. PubMed ID: 16759046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
    Posit Aware; 2006; Spec No():17-22. PubMed ID: 16596730
    [No Abstract]   [Full Text] [Related]  

  • 29. What is the difference between phenotyping and genotyping?
    Wilder TL
    Surviv News (Atlanta Ga); 2001 May; ():13, 20. PubMed ID: 11682727
    [No Abstract]   [Full Text] [Related]  

  • 30. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.
    Wegner SA; Wallace MR; Aronson NE; Tasker SA; Blazes DL; Tamminga C; Fraser S; Dolan MJ; Stephan KT; Michael NL; Jagodzinski LL; Vahey MT; Gilcrest JL; Tracy L; Milazzo MJ; Murphy DJ; McKenna P; Hertogs K; Rinehart A; Larder B; Birx DL;
    Clin Infect Dis; 2004 Mar; 38(5):723-30. PubMed ID: 14986258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant resistance interpretations in multi-treated HIV-1 patients.
    Re MC; Bon I; Schiavone P; Vitone F; Gibellini D
    Int J Antimicrob Agents; 2005 Mar; 25(3):211-5. PubMed ID: 15737514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance and replication capacity assays: clinical utility and interpretation.
    Haubrich RH
    Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using HIV resistance tests in clinical practice.
    Taylor S; Jayasuriya A; Smit E
    J Antimicrob Chemother; 2009 Aug; 64(2):218-22. PubMed ID: 19535382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.
    Weinstock HS; Zaidi I; Heneine W; Bennett D; Garcia-Lerma JG; Douglas JM; LaLota M; Dickinson G; Schwarcz S; Torian L; Wendell D; Paul S; Goza GA; Ruiz J; Boyett B; Kaplan JE
    J Infect Dis; 2004 Jun; 189(12):2174-80. PubMed ID: 15181563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High antiretroviral drug adherence key in effort to avoid drug resistance. New study highlights its importance.
    AIDS Alert; 2005 Mar; 20(3):25, 27-8. PubMed ID: 15789470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.
    Scosyrev E
    Clin Lab Sci; 2006; 19(4):231-45; quiz 246-9. PubMed ID: 17181129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
    Koyalta D; Charpentier C; Beassamda J; Rey E; Si-Mohamed A; Djemadji-Oudjeil N; Bélec L
    Clin Infect Dis; 2009 Jul; 49(1):155-9. PubMed ID: 19480574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.